These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15140628)

  • 1. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
    Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
    Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
    Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
    Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin B2 and GPR100 receptors: a paradigm for receptor signal transduction pharmacology.
    Meini S; Bellucci F; Cucchi P; Giuliani S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Boels K; Maggi CA
    Br J Pharmacol; 2004 Dec; 143(8):938-41. PubMed ID: 15545289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
    Kam YL; Ro JY; Kim HJ; Choo HY
    Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.
    Bellucci F; Meini S; Cucchi P; Catalani C; Reichert W; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Br J Pharmacol; 2003 Oct; 140(3):500-6. PubMed ID: 12970081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
    Robert C; Pruneau D; Paquet JL
    Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
    Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
    Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor.
    Cucchi P; Meini S; Quartara L; Giolitti A; Zappitelli S; Rotondaro L; Maggi CA
    Peptides; 2002 Aug; 23(8):1457-63. PubMed ID: 12182947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
    Griesbacher T; Rainer I
    Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
    Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus.
    Ballet S; De Wachter R; Van Rompaey K; Tömböly C; Feytens D; Töth G; Quartara L; Cucchi P; Meini S; Tourwé D
    J Pept Sci; 2007 Mar; 13(3):164-70. PubMed ID: 17266049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.